INNV Stock: Price, Earnings History and SEC Filings
InnovAge Holding Corp. (INNV) last traded at $9.19, down 0.54% on the latest session and up 4.4% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $0.06 against an analyst estimate of $0.09, a miss of 33.3%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
INNV earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Sep 8, 2026 | $0.06 | $0.09 | -33.33% |
| Mar 2026 | May 5, 2026 | $-0.22 | $0.06 | -466.67% |
| Dec 2025 | Feb 3, 2026 | $0.08 | $0.04 | +100.00% |
| Sep 2025 | Nov 4, 2025 | $0.06 | $0.01 | +500.00% |
INNV beat the analyst EPS estimate in 2 of its last 4 reported quarters. Source: Nasdaq.
How INNV reacts to earnings
Across its last 8 earnings releases, INNV moved 11.5% on average the next session, in either direction. It rose after 5 of 8 reports.
| Report date | Released | Next-session move |
|---|---|---|
| 2026-09-08 | After close | +4.85% |
| 2026-05-05 | After close | +2.01% |
| 2026-02-03 | After close | +37.46% |
| 2025-11-04 | After close | -17.56% |
| 2025-09-09 | After close | -2.81% |
| 2025-05-06 | After close | +14.39% |
| 2025-02-04 | After close | -9.08% |
| 2024-11-05 | After close | +3.79% |
Based on the dates of earnings-release 8-K filings (SEC EDGAR) and daily closing prices (Yahoo Finance). Past reactions do not predict future ones.
INNV financial history
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2026 | $990M | -$3M | $50M | -0.3% | $-0.02 |
| 2025 | $854M | -$30M | $27M | -3.6% | $-0.22 |
| 2024 | $764M | -$21M | -$45M | -2.8% | $-0.16 |
| 2023 | $688M | -$41M | -$3M | -5.9% | $-0.30 |
| 2022 | $699M | -$7M | -$11M | -0.9% | $-0.05 |
| 2021 | $638M | -$44M | -$25M | -6.9% | $-0.36 |
| 2020 | $567M | $26M | $32M | 4.6% | $0.19 |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for INNV
- DEF 14A · Oct 22, 2026
- 8-K · Sep 24, 2026Other events, Financial statements and exhibits
- 424B4 · Sep 24, 2026
- 424B7 · Sep 22, 2026
- 10-K · Sep 9, 2026
- 8-K · Sep 8, 2026Results of operations, Financial statements and exhibits
- S-3 · Jul 31, 2026
- 8-K · May 18, 2026Regulation FD disclosure
- 8-K · May 12, 2026Officer or director change, Regulation FD disclosure, Financial statements and exhibits
- 10-Q · May 8, 2026
Insider filing activity
INNV insiders filed 11 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
INNV news
- Pediatrix Medical Group (MD) Beats Q3 Earnings and Revenue EstimatesOct 29, 2026 · finance.yahoo.com
- California Healthcare Stocks Tied To State Funding And Senior Care DemandOct 24, 2026 · finance.yahoo.com
- InnovAge to Announce Fiscal First Quarter 2027 Financial Results and Host Conference Call Tuesday, November 3, 2026Oct 20, 2026 · finance.yahoo.com
About InnovAge Holding Corp.
InnovAge Holding Corp. (INNV) is a US-listed public company on Nasdaq. The SEC classifies its business as Services-health Services. It is incorporated in DE. Its fiscal year ends in June.